Tag Archives: vrx

Valeant Subpoenaed By Federal Prosecutors On Pricing

Valeant Pharmaceuticals (VRX) late Wednesday said it has received subpoenas from U.S. Attorneys in Massachusetts and the Southern District of New York related to drug pricing and how it helps patients pay for drugs. It comes as Valeant and a slew of biotechs such as Biogen (BIIB), Gilead Sciences (GILD), Amgen (AMGN) and Celgene (CELG). Valeant said in a statement: “Most of the materials requested by the subpoenas relate to documents with respect

Valeant Defended After Politics-Induced Sell-Off

Analysts came to the defense of Canadian drug giant Valeant Pharmaceuticals (VRX) on Tuesday, after the stock sold off on word that some members of Congress were targeting it for its pricing policy. Valeant stock plunged 16.5% Monday, partly due to a larger drug sell-off but also because a group of congressional Democrats sent a letter to Rep. Jason Chaffetz, chair of the House Committee on Oversight and Government Reform, requesting a subpoena to

Facebook, Starbucks Boost Big-Cap Heft With Big Buys

About three years after Facebook (FB) acquired Instagram for $1 billion, the photo-sharing site said Tuesday that it hit the 400 million user milestone. Its reach spans the globe — 75% of Instagrammers live outside the U.S., it said. Today’s Screen of the Day features Big Cap Leaders, top-rated institutional-quality stocks such as Facebook, Starbucks (SBUX) and Valeant Pharmaceuticals (VRX). Here are several big caps that have sought to maintain